Insider Shareholders with Direct Ownership of Eye Point Pharmaceuticals, Inc. (EYPT)
This section provides a comprehensive overview of the insiders with direct ownership of Eye Point Pharmaceuticals, Inc. (EYPT). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
EyePoint Pharmaceuticals, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 445,595 | 187,667 | 294,346 $3.49 Million | 27 |
Jan 06, 2026
Added 20.33%
|
|
|
Therapeutics Ocumension
Director |
0 | 2,910,500 | 100,221 $1.19 Million | 3 |
Jan 11, 2024
Reduced 95.02%
|
|
George Elston
Chief Financial Officer |
142,922 | 65,942 | 91,852 $1.09 Million | 24 |
Jan 06, 2026
Reduced 4.66%
|
|
Jay S. Duker
President and CEO |
271,871 | 199,776 | 77,752 $921,361 | 29 |
Jan 06, 2026
Reduced 11.45%
|
|
Dario A. Paggiarino
Chief Medical Officer |
223,192 | 165,022 | 67,080 $794,898 | 30 |
Mar 30, 2024
Reduced 9.57%
|
|
David Scott Jones
SVP & Chief Commercial Officer |
121,587 | 88,256 | 44,916 $532,254 | 24 |
Feb 09, 2024
Reduced 3.65%
|
| 38,500 | 0 | 38,500 $456,225 | 8 |
Jul 11, 2025
Added 4.94%
|
|
| 17,400 | 0 | 21,400 $253,590 | 4 |
Jan 05, 2025
Added 31.85%
|
|
|
Michael Craig Pine
Chief Corp Dev.&Strat. Officer |
61,285 | 50,966 | 13,662 $161,894 | 5 |
Jan 06, 2024
Reduced 30.4%
|
| 13,150 | 0 | 13,150 $155,827 | 4 |
Aug 21, 2024
Added 27.55%
|
|
| 9,967 | 0 | 9,967 $118,108 | 4 |
Aug 20, 2024
Added 20.48%
|
|
| 4,400 | 0 | 8,016 $94,989 | 2 |
Jun 22, 2021
Added 23.77%
|
|
| 4,000 | 0 | 4,000 $47,400 | 2 |
Jun 23, 2024
Added 33.33%
|
|
| 36,725 | 34,875 | 1,850 $21,922 | 9 |
Jul 12, 2024
Reduced 86.27%
|
|
|
Ramiro Ribeiro
Chief Medical Officer |
48,917 | 51,639 | 0 $0 | 5 |
Jan 05, 2026
Reduced 100.0%
|